1
|
Bonaventura F, Scheler S, Novak V, Olbinado MP, Wagner M, Grünzweig C, Zuern A. Does needle clogging change the spatial distribution of injected drug in tissue? New insights by X-ray computed tomography. Eur J Pharm Biopharm 2025; 207:114615. [PMID: 39694077 DOI: 10.1016/j.ejpb.2024.114615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2024] [Revised: 12/04/2024] [Accepted: 12/16/2024] [Indexed: 12/20/2024]
Abstract
Prefilled syringes (PFS) are primary packaging materials that offer convenience and safety for subcutaneous injection of parenteral drug solutions. However, an increasingly common problem with the trend towards higher drug concentrations is the clogging of the needle during storage due to evaporative water loss and consequent solidification of the drug. In contrast to all previous studies on this topic, this work focuses on pharmacokinetically relevant aspects and investigates the effects of needle clogging on the spatial distribution of the injected drug in the tissue. X-ray computed tomography (XCT) (both tube-based and synchrotron-based) was used to visualize and analyze the spreading pattern and the fate of the injected liquid in porcine skin. By using controlled injection and force measurement the tissue distribution was correlated with the plunger force profile and the fluid dynamics of the jet. Studies of monoclonal antibody solution demonstrate that clogs, which are formed by evaporation of water and solidification of drug solution in the needle tip, usually dissolve in the flow of the liquid during injection. In the initial injection phase, the liquid jet starts to escape the needle only through a narrow channel in the clog. The resulting high dynamic pressure can alter the distribution of the liquid in the tissue, causing a long tail of liquid that penetrates deep into the fibrous network of the subcutaneous layer. However, the volume of this tail was calculated to be low relative to the overall volume of the injected drug solution (less than 2.4%) and is therefore unlikely to have a significant effect on the absorption kinetics of the injected drug. In addition, it was shown that if a clog were to enter the tissue, it would quickly dissolve.
Collapse
Affiliation(s)
- Fabiano Bonaventura
- Novartis Pharmaceutical Manufacturing GmbH, Biochemiestraße 10, 6336 Langkampfen, Austria
| | - Stefan Scheler
- Novartis Pharmaceutical Manufacturing GmbH, Biochemiestraße 10, 6336 Langkampfen, Austria.
| | - Vladimir Novak
- ANAXAM, Park Innovaare, Parkstrasse 1, 5234 Villigen, Switzerland
| | - Margie P Olbinado
- ANAXAM, Park Innovaare, Parkstrasse 1, 5234 Villigen, Switzerland; Paul Scherrer Institut, Forschungsstrasse 111, 5232 Villigen, Switzerland
| | - Matthias Wagner
- ANAXAM, Park Innovaare, Parkstrasse 1, 5234 Villigen, Switzerland
| | | | | |
Collapse
|
2
|
Hu G, Bonanno D, Su Y, Zhao X, Krishnamachari Y, Forrest W, Persak S, Givand J, Mannes D, Olbinado M, Wagner M, Grünzweig C, Novak V. Unraveling Pre-filled Syringe Needle Clogging: Exploring a Fresh Outlook Through Innovative Techniques. Pharm Res 2024; 41:547-556. [PMID: 38326531 DOI: 10.1007/s11095-024-03673-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 01/28/2024] [Indexed: 02/09/2024]
Abstract
OBJECTIVE This study aimed to investigate the movement of liquid in the needle region of staked-in-needle pre-filled syringes using neutron imaging and synchrotron X-ray tomography. The objective was to gain insights into the dynamics of liquid presence and understand the factors contributing to needle clogging. METHODS Staked-in-needle pre-filled syringes were examined using neutron radiography and synchrotron X-ray phase-contrast computed tomography. Neutron radiography provided a 2D visualization of liquid presence in the needle, while synchrotron X-ray tomography offered high-resolution 3D imaging to study detailed morphological features of the liquid. RESULTS Neutron radiography revealed liquid presence in the needle region for as-received samples and after temperature and pressure cycling. Pressure cycling had a more pronounced effect on liquid formation. Synchrotron X-ray tomography confirmed the presence of liquid and revealed various morphologies, including droplets of different sizes, liquid segments blocking sections of the needle, and a thin layer covering the needle wall. Liquid presence was also observed between the steel needle and the glass barrel. CONCLUSIONS The combination of neutron imaging and synchrotron X-ray tomography provided valuable insights into the dynamics of liquid movement in staked-in-needle pre-filled syringes. Temperature and pressure cycling were found to contribute to additional liquid formation, with pressure changes playing a significant role. The detailed morphological analysis enhanced the understanding of microstructural arrangements within the needle. This research contributes to addressing the issue of needle clogging and can guide the development of strategies to improve pre-filled syringe performance.
Collapse
Affiliation(s)
- Guangli Hu
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA.
| | - Daniel Bonanno
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - Yongchao Su
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA.
| | - Xi Zhao
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - Yogita Krishnamachari
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - William Forrest
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - Steven Persak
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - Jeffrey Givand
- Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc, Rahway, NJ, 07065, USA
| | - David Mannes
- ANAXAM, PARK INNOVAARE: deliveryLAB, CH-5234, Villigen, Switzerland
- Paul Scherrer Institute (PSI), Forschungsstrasse 111, 5232, Villigen, Switzerland
| | - Margie Olbinado
- ANAXAM, PARK INNOVAARE: deliveryLAB, CH-5234, Villigen, Switzerland
- Paul Scherrer Institute (PSI), Forschungsstrasse 111, 5232, Villigen, Switzerland
| | - Matthias Wagner
- ANAXAM, PARK INNOVAARE: deliveryLAB, CH-5234, Villigen, Switzerland
| | | | - Vladimir Novak
- ANAXAM, PARK INNOVAARE: deliveryLAB, CH-5234, Villigen, Switzerland
| |
Collapse
|